prednisone has been researched along with Hematologic Neoplasms in 45 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess metformin's prophylactic effectiveness of prednisone-induced hyperglycemia among hematological cancer patients." | 9.34 | Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers. ( Guantai, EM; Nyamu, DG; Ochola, LA; Weru, IW, 2020) |
| "We hypothesized that initial treatment of acute graft-versus-host disease (GVHD) with low-dose glucocorticoids (prednisone-equivalent dose of 1 mg/kg per day) instead of standard-dose glucocorticoids (prednisone-equivalent dose of 2 mg/kg per day) does not compromise major transplantation outcomes." | 7.75 | Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. ( Appelbaum, FR; Boeckh, M; Carpenter, PA; Deeg, HJ; Doney, K; Flowers, ME; Furlong, T; Lee, S; Marr, KA; Martin, PJ; McDonald, GB; Mielcarek, M; Nash, RA; Storb, R; Storer, BE, 2009) |
| "Lubiprostone was more effective than stimulant laxatives at treating vinca alkaloid-induced intractable constipation in patients with hematological malignancies, and its use could enable safe vinca alkaloid chemotherapy." | 5.56 | Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis. ( Fukuda, H; Hayashi, T; Imai, T; Kawada, K; Miyamura, M; Morita, Y; Ohta, T; Tanaka, K, 2020) |
| "To assess metformin's prophylactic effectiveness of prednisone-induced hyperglycemia among hematological cancer patients." | 5.34 | Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers. ( Guantai, EM; Nyamu, DG; Ochola, LA; Weru, IW, 2020) |
| "Lamivudine is a nucleoside analogue that can directly suppress HBV replication." | 5.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| "To define high-risk acute graft-versus-host disease (GVHD) at onset, we examined the initial GVHD stage and grade of 864 patients at the University of Minnesota who received uniform therapy with prednisone 60 mg/m(2) per d." | 5.16 | What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score. ( DeFor, TE; MacMillan, ML; Weisdorf, DJ, 2012) |
| "Twelve patients with a history of childhood malignancy and chronic hepatitis B were treated with prednisone for 4 weeks (0." | 5.10 | Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy. ( Benesch, M; Deutsch, J; Dornbusch, HJ; Kerbl, R; Kessler, HH; Lackner, H; Moser, A; Schwinger, W; Sovinz, P; Urban, C, 2002) |
| " Prophylaxis against graft-versus-host disease (GVHD) consisted of cyclosporine alone for 5 patients and CSA plus methotrexate for 11 patients." | 5.08 | Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. ( Appelbaum, FR; Bensinger, WI; Benyunes, M; Buckner, CD; Clift, R; Demirer, T; Lee, M; Martin, P; Rowley, S; Schiller, G; Shannon-Dorcy, K; Storb, R, 1996) |
| "The hyper-CVAD/methotrexate-cytarabine (H-CVAD/ MTX-AraC) chemotherapy protocol has been one of the standard treatments for hematological malignancies, such as mantle cell lymphoma (MCL), Burkitt lymphoma (BL), and B-cell and T-cell acute lymphoblastic leukemia." | 4.02 | Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL. ( Algarra-Algarra, JL; Gómez-Catalán, I; Hernández-Fernández, F; Ibañez-García, Á; Marín-Sánchez, A; Martínez-Fernández, G; Montoya-Morcillo, MC; Romero-Macías, JR, 2021) |
| "We hypothesized that initial treatment of acute graft-versus-host disease (GVHD) with low-dose glucocorticoids (prednisone-equivalent dose of 1 mg/kg per day) instead of standard-dose glucocorticoids (prednisone-equivalent dose of 2 mg/kg per day) does not compromise major transplantation outcomes." | 3.75 | Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes. ( Appelbaum, FR; Boeckh, M; Carpenter, PA; Deeg, HJ; Doney, K; Flowers, ME; Furlong, T; Lee, S; Marr, KA; Martin, PJ; McDonald, GB; Mielcarek, M; Nash, RA; Storb, R; Storer, BE, 2009) |
| " Ofatumumab in combination with prednisone is safe and a phase II examination of efficacy is ongoing." | 2.80 | Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results. ( Alsina, M; Anasetti, C; Ayala, E; Betts, BC; Fernandez, HF; Field, T; Kharfan-Dabaja, MA; Kim, J; Locke, FL; Mishra, A; Nishihori, T; Ochoa-Bayona, L; Perez, L; Pidala, J; Riches, M, 2015) |
| "For the management of multiple myeloma, high-dose chemotherapy, mainly melphalan with autologous stem cell transplantation, has become the standard treatment even for elderly patients less than 65 years of age." | 2.44 | [Hematological malignancies]. ( Usui, N, 2007) |
| " The prednisone dosage played no role in CH incidence in patients with HL." | 1.72 | Does transitory steroid-induced central hypothyroidism in children treated for haematological malignancies warrant clinical intervention? ( Grizelj, A; Kranjčec, I; Matijašić, N; Oletić, L; Štromar, L, 2022) |
| " Only systemic corticosteroids have consistently proven successful in suppressing the rash; however, the response is often only partial, and symptoms tend to recur as the dosage is tapered." | 1.56 | Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy. ( Gates, G; Lor, M; Yu, Y, 2020) |
| "Lubiprostone was more effective than stimulant laxatives at treating vinca alkaloid-induced intractable constipation in patients with hematological malignancies, and its use could enable safe vinca alkaloid chemotherapy." | 1.56 | Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis. ( Fukuda, H; Hayashi, T; Imai, T; Kawada, K; Miyamura, M; Morita, Y; Ohta, T; Tanaka, K, 2020) |
| "Oral mucositis was reduced in patients treated with RIC and in patients treated during recent years, when oral care was intensified." | 1.40 | Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients. ( Dahllöf, G; Heimdahl, A; Legert, KG; Remberger, M; Ringdén, O, 2014) |
| "Acquired ichthyosis is a rare condition that can reveal an unsuspected haematological malignancy, thus allowing early diagnosis and management." | 1.38 | [Acquired ichthyosis and haematological malignancies: five cases]. ( Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ, 2012) |
| "To examine the association of OP with hematologic malignancies and to assess the clinical course of affected patients." | 1.34 | Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion. ( Daniels, CE; Markovic, SN; Myers, JL; Ryu, JH; Utz, JP, 2007) |
| "Tacrolimus (FK506) is a potent macrolide lactone immunosuppressant that is used in the prevention of solid organ rejection." | 1.31 | Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment. ( Ilan, Y; Menachem, Y; Nagler, A, 2001) |
| "Lamivudine is a nucleoside analogue that can directly suppress HBV replication." | 1.31 | Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy. ( Motta, M; Pelizzari, A; Puoti, M; Rossi, G, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.67) | 18.2507 |
| 2000's | 15 (33.33) | 29.6817 |
| 2010's | 20 (44.44) | 24.3611 |
| 2020's | 7 (15.56) | 2.80 |
| Authors | Studies |
|---|---|
| Othman, T | 1 |
| Penaloza, J | 1 |
| Zhang, S | 1 |
| Daniel, CE | 1 |
| Gaut, D | 1 |
| Oliai, C | 1 |
| Brem, EA | 1 |
| Baweja, A | 1 |
| Ly, J | 1 |
| Reid, J | 1 |
| Pinter-Brown, L | 1 |
| Lee, M | 2 |
| Abdulhaq, H | 1 |
| Tuscano, J | 1 |
| Kranjčec, I | 1 |
| Matijašić, N | 1 |
| Oletić, L | 1 |
| Grizelj, A | 1 |
| Štromar, L | 1 |
| Ochola, LA | 1 |
| Nyamu, DG | 1 |
| Guantai, EM | 1 |
| Weru, IW | 1 |
| Lor, M | 1 |
| Gates, G | 1 |
| Yu, Y | 1 |
| Kawada, K | 1 |
| Ohta, T | 1 |
| Fukuda, H | 1 |
| Hayashi, T | 1 |
| Tanaka, K | 1 |
| Imai, T | 1 |
| Morita, Y | 1 |
| Miyamura, M | 1 |
| Bailey, CAR | 1 |
| Laurain, DA | 1 |
| Sheinbein, DM | 1 |
| Jones, HA | 1 |
| Compton, LA | 1 |
| Rosman, IS | 1 |
| Marín-Sánchez, A | 1 |
| Martínez-Fernández, G | 1 |
| Gómez-Catalán, I | 1 |
| Montoya-Morcillo, MC | 1 |
| Algarra-Algarra, JL | 1 |
| Ibañez-García, Á | 1 |
| Hernández-Fernández, F | 1 |
| Romero-Macías, JR | 1 |
| Martin, PJ | 5 |
| Storer, BE | 3 |
| Inamoto, Y | 2 |
| Flowers, MED | 1 |
| Carpenter, PA | 4 |
| Pidala, J | 2 |
| Palmer, J | 1 |
| Arora, M | 1 |
| Jagasia, M | 1 |
| Arai, S | 1 |
| Cutler, CS | 1 |
| Lee, SJ | 2 |
| Crespo, J | 1 |
| Esteban, R | 1 |
| Torres, C | 1 |
| Oyagüez, I | 1 |
| Casado, MÁ | 1 |
| Buti, M | 1 |
| Moore, DC | 1 |
| Arnall, JR | 1 |
| Plesca, DC | 1 |
| Sato, S | 1 |
| Tanaka, E | 1 |
| Tamai, Y | 1 |
| Salem, KH | 1 |
| Brockert, AK | 1 |
| Mertens, R | 1 |
| Drescher, W | 1 |
| Legert, KG | 1 |
| Remberger, M | 1 |
| Ringdén, O | 1 |
| Heimdahl, A | 1 |
| Dahllöf, G | 1 |
| Vassallo, C | 1 |
| Pezzini, C | 1 |
| Carugno, A | 1 |
| Derlino, F | 1 |
| Croci, G | 1 |
| Paulli, M | 1 |
| Borroni, G | 1 |
| Rancea, M | 2 |
| Will, A | 1 |
| Borchmann, P | 1 |
| Monsef, I | 2 |
| Engert, A | 3 |
| Skoetz, N | 2 |
| Kalisch, A | 1 |
| Wilhelm, M | 1 |
| Erbguth, F | 1 |
| Birkmann, J | 1 |
| Kim, J | 1 |
| Betts, BC | 1 |
| Alsina, M | 1 |
| Ayala, E | 1 |
| Fernandez, HF | 1 |
| Field, T | 1 |
| Kharfan-Dabaja, MA | 1 |
| Locke, FL | 1 |
| Mishra, A | 1 |
| Nishihori, T | 1 |
| Ochoa-Bayona, L | 1 |
| Perez, L | 1 |
| Riches, M | 1 |
| Anasetti, C | 2 |
| Nobile, A | 1 |
| Valenti, A | 1 |
| Aubert, JD | 1 |
| Beigelman, C | 1 |
| Letovanec, I | 1 |
| Bongiovanni, M | 1 |
| Prats-Martín, C | 1 |
| Morales-Camacho, RM | 1 |
| Blum-Domínguez, MA | 1 |
| Cabrera-Pérez, R | 1 |
| Bernal, R | 1 |
| Caballero-Velázquez, T | 1 |
| Pérez-Simón, JA | 1 |
| Saito, Y | 1 |
| Susukida, I | 1 |
| Uzuka, Y | 1 |
| Kanai, H | 1 |
| Vacas, AS | 1 |
| Torre, AC | 1 |
| Bollea-Garlatti, ML | 1 |
| Warley, F | 1 |
| Galimberti, RL | 1 |
| Mielcarek, M | 2 |
| Boeckh, M | 1 |
| McDonald, GB | 1 |
| Deeg, HJ | 2 |
| Nash, RA | 2 |
| Flowers, ME | 2 |
| Doney, K | 2 |
| Lee, S | 1 |
| Marr, KA | 1 |
| Furlong, T | 2 |
| Storb, R | 4 |
| Appelbaum, FR | 3 |
| Berrady, R | 1 |
| Baybay, H | 1 |
| Khammar, Z | 1 |
| Lahlou, M | 1 |
| Lamchachti, L | 1 |
| Gallouj, S | 1 |
| El Hatimi, A | 1 |
| Mernissi, FZ | 1 |
| Bono, W | 1 |
| MacMillan, ML | 1 |
| DeFor, TE | 1 |
| Weisdorf, DJ | 1 |
| Hübel, K | 1 |
| Bauer, K | 1 |
| Sang, W | 1 |
| Wang, CF | 1 |
| Cheng, YF | 1 |
| Liu, X | 1 |
| Li, XX | 1 |
| Gulinar, A | 1 |
| Li, JZ | 1 |
| Zhang, W | 1 |
| Sagnelli, E | 1 |
| Pisaturo, M | 1 |
| Sagnelli, C | 1 |
| Coppola, N | 1 |
| Sandmaier, BM | 2 |
| Lackner, H | 1 |
| Moser, A | 1 |
| Benesch, M | 1 |
| Deutsch, J | 1 |
| Kessler, HH | 1 |
| Kerbl, R | 1 |
| Schwinger, W | 1 |
| Dornbusch, HJ | 1 |
| Sovinz, P | 1 |
| Urban, C | 1 |
| Avivi, I | 1 |
| Robinson, S | 1 |
| Goldstone, A | 1 |
| Ogawa, M | 1 |
| Arcaini, L | 1 |
| Orlandi, E | 1 |
| Scotti, M | 1 |
| Brusamolino, E | 1 |
| Passamonti, F | 1 |
| Burcheri, S | 1 |
| Colombo, N | 1 |
| Vanelli, L | 1 |
| Sbalzarini, G | 1 |
| Lazzarino, M | 1 |
| Burroughs, L | 1 |
| Leisenring, W | 2 |
| Diaconescu, R | 1 |
| Maloney, DG | 1 |
| Maris, MB | 1 |
| Chauncey, TR | 1 |
| Shizuru, JA | 1 |
| Blume, KG | 1 |
| Hegenbart, U | 1 |
| Niederwieser, D | 1 |
| Forman, S | 1 |
| Bruno, B | 1 |
| Woolfrey, A | 1 |
| Kober, T | 1 |
| Hülsewede, H | 1 |
| Bohlius, J | 1 |
| Daniels, CE | 1 |
| Myers, JL | 1 |
| Utz, JP | 1 |
| Markovic, SN | 1 |
| Ryu, JH | 1 |
| Sari, I | 1 |
| Altuntas, F | 1 |
| Kocyigit, I | 1 |
| Sisman, Y | 1 |
| Eser, B | 1 |
| Unal, A | 2 |
| Fen, T | 1 |
| Ferahbas, A | 1 |
| Ozturk, A | 1 |
| Cetin, M | 1 |
| Usui, N | 1 |
| Ludwig, H | 1 |
| Strasser-Weippl, K | 1 |
| Schreder, M | 1 |
| Zojer, N | 1 |
| Bensinger, WI | 1 |
| Buckner, CD | 1 |
| Shannon-Dorcy, K | 1 |
| Rowley, S | 1 |
| Benyunes, M | 1 |
| Clift, R | 1 |
| Martin, P | 1 |
| Demirer, T | 1 |
| Schiller, G | 1 |
| Miyazaki, H | 1 |
| Hirano, M | 1 |
| Niitsu, N | 1 |
| Kato, M | 1 |
| Shikoshi, K | 1 |
| Umeda, M | 1 |
| Nagler, A | 1 |
| Menachem, Y | 1 |
| Ilan, Y | 1 |
| Ancín, I | 1 |
| Ferrá, C | 1 |
| Gallardo, D | 1 |
| Peris, J | 1 |
| Berlanga, J | 1 |
| Gonzalez, JR | 1 |
| Virgili, N | 1 |
| Grañena, A | 1 |
| Rossi, G | 1 |
| Pelizzari, A | 1 |
| Motta, M | 1 |
| Puoti, M | 1 |
| Kiem, HP | 1 |
| Sanders, JE | 1 |
| Witherspoon, R | 1 |
| Thompson, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Improving Outcomes Assessment in Chronic GVHD[NCT00637689] | 601 participants (Actual) | Observational | 2007-09-30 | Active, not recruiting | |||
| Cryoprotection of Chemotherapy-induced Oral Mucositis After Autologous Stem Cell Transplantation, a Randomized Study[NCT03203733] | 182 participants (Actual) | Interventional | 2017-06-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for prednisone and Hematologic Neoplasms
| Article | Year |
|---|---|
Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.
Topics: Acneiform Eruptions; Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and ove | 2021 |
Progressive multifocal leukoencephalopathy in patients with a hematological malignancy: review of therapeutic options.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; | 2014 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophospham | 2012 |
[Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD56 Antigen; Cyclophosphamid | 2012 |
Rituximab-based treatment, HCV replication, and hepatic flares.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2012 |
Clinical use of rituximab in haematological malignancies.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2003 |
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
[Hematological malignancies].
Topics: Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl | 2007 |
Advances in the treatment of hematological malignancies: current treatment approaches in multiple myeloma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cli | 2007 |
[Effective clinical use of cyclophosphamide in hematological malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 1996 |
6 trials available for prednisone and Hematologic Neoplasms
| Article | Year |
|---|---|
Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers.
Topics: Adult; Aged; Blood Glucose; Fasting; Female; Hematologic Neoplasms; Humans; Hyperglycemia; Hypoglyce | 2020 |
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Topics: Adult; Aged; Calcineurin Inhibitors; Chronic Disease; Disease Progression; Endpoint Determination; F | 2017 |
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Chron | 2015 |
What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Child; Child, Preschool; Di | 2012 |
Serological and molecular response on combined antiviral treatment in children with chronic hepatitis B after pediatric malignancy.
Topics: 2-Aminopurine; Adolescent; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Drug Therapy, Comb | 2002 |
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Topics: Adult; Aged; Antigens, CD34; Blood Cells; Cell Count; Cell Separation; Cyclophosphamide; Cyclosporin | 1996 |
28 other studies available for prednisone and Hematologic Neoplasms
| Article | Year |
|---|---|
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hem | 2022 |
Does transitory steroid-induced central hypothyroidism in children treated for haematological malignancies warrant clinical intervention?
Topics: Child; Congenital Hypothyroidism; Dexamethasone; Female; Hematologic Neoplasms; Humans; Hypothyroidi | 2022 |
Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy.
Topics: Hematologic Neoplasms; Humans; Neoplasm Recurrence, Local; Omalizumab; Prednisone; Skin Diseases | 2020 |
Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Pro | 2020 |
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cycloph | 2021 |
Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studi | 2017 |
Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting.
Topics: Ambulatory Care; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; C | 2018 |
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells | 2019 |
Avascular necrosis after chemotherapy for haematological malignancy in childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arthroplasty, Replacement, Hip; Child; C | 2013 |
Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosp | 2014 |
Cutaneous blastic plasmacytoid dendritic cell neoplasm: successful palliative treatment with oral prednisone in an elderly patient.
Topics: Aged, 80 and over; Antineoplastic Agents, Hormonal; Dendritic Cells; Hematologic Neoplasms; Humans; | 2015 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine | 2014 |
Granulomatous Reaction to Pneumocystis jirovecii Diagnosed in a Bronchoalveolar Lavage: A Case Report.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bronch | 2015 |
Strong periodic acid-schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; | 2016 |
Noninvasive early detection of anthracycline-induced cardiotoxicity in patients with hematologic malignancies using the phased tracking method.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Co | 2016 |
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Topics: Adalimumab; Adult; Age Factors; Aged; Arthritis, Rheumatoid; Cyclosporine; Dermatologic Agents; Etan | 2017 |
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Topics: Acute Disease; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Glucocorticoids; G | 2009 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Ant | 2012 |
Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Child; Child, Preschoo | 2013 |
Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combi | 2004 |
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Drug Administratio | 2005 |
Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion.
Topics: Acute Disease; Adult; Aged; Biopsy; Bronchi; Cryptogenic Organizing Pneumonia; Diagnosis, Differenti | 2007 |
The effect of budesonide mouthwash on oral chronic graft versus host disease.
Topics: Adult; Budesonide; Candidiasis, Oral; Chronic Disease; Cohort Studies; Cyclosporine; Drug Evaluation | 2007 |
[Doxorubicin-induced myocardial damage in elderly patients with hematologic malignancies].
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols | 1997 |
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Cyclosporine; Drug Evaluation; Drug Resistance; Female | 2001 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cy | 2001 |
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Bone Marrow Transplanta | 2002 |